AIM
TMO icon

abrdn Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

abrdn Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$76.1M Sell
436,380
-415,682
-49% -$69.8M 0.26% 106
2017
Q1 		$131M Sell
852,062
-35,118
-4% -$5.37M 0.43% 81
2016
Q4 		$125M Buy
887,180
+89,056
+11% +$13.1M 0.44% 83
2016
Q3 		$127M Buy
798,124
+687,018
+618% +$106M 0.52% 71
2016
Q2 		$16.4M Sell
111,106
-369
-0.3% -$54.5K 0.07% 127
2016
Q1 		$15.8M Buy
+111,475
New +$14.9M 0.07% 127
2015
Q1 		– Sell
-16,415
Closed -$2.06M – 406
2014
Q4 		$2.06M Sell
16,415
-266
-2% -$32.3K 0.01% 205
2014
Q3 		$2.03M Sell
16,681
-242
-1% -$29.4K 0.01% 224
2014
Q2 		$2M Sell
16,923
-405
-2% -$47.7K 0.01% 219
2014
Q1 		$2.08M Buy
17,328
+1,450
+9% +$172K 0.01% 190
2013
Q4 		$1.77M Buy
15,878
+426
+3% +$42.4K 0.01% 230
2013
Q3 		$1.42M Sell
15,452
-93
-0.6% -$8.41K 0.01% 225
2013
Q2 		$1.32M Buy
+15,545
New +$1.29M 0.01% 221

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

abrdn Investment Management's TMO Position: Q2 2017 in Review

abrdn Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 49% in Q2 2017, selling an estimated $69.8M and leaving 436,380 shares worth $76.1M. The position accounts for 0.26% of the portfolio, ranked #106.

abrdn Investment Management first reported a position in TMO in Q2 2013 and has held it in 13 quarters since. The position peaked at $131M in Q1 2017. 1,159 funds tracked by Wall St. Rank hold TMO as of Q2 2017.

  • abrdn Investment Management held 436,380 shares of Thermo Fisher Scientific worth $76.1M as of Q2 2017.
  • abrdn Investment Management sold 415,682 Thermo Fisher Scientific shares in Q2 2017, an estimated $69.8M.
  • Thermo Fisher Scientific made up 0.26% of abrdn Investment Management's portfolio in Q2 2017, its #106 holding.
  • abrdn Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 13 quarters since.
  • abrdn Investment Management's Thermo Fisher Scientific position peaked at $131M in Q1 2017.
  • 1,159 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2017.

Based on abrdn Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.